KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Assets (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Return on Assets for 13 consecutive years, with 0.04% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 4.0% year-over-year to 0.04%, compared with a TTM value of 0.04% through Dec 2025, up 4.0%, and an annual FY2025 reading of 0.04%, up 4.0% over the prior year.
  • Return on Assets was 0.04% for Q4 2025 at Travere Therapeutics, up from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.39% in Q2 2024 and bottomed at 0.33% in Q3 2021.
  • Average Return on Assets over 5 years is 0.04%, with a median of 0.0% recorded in 2024.
  • The sharpest move saw Return on Assets surged 36bps in 2022, then crashed -39bps in 2025.
  • Year by year, Return on Assets stood at 0.28% in 2021, then skyrocketed by 127bps to 0.08% in 2022, then grew by 4bps to 0.08% in 2023, then plummeted by -102bps to 0.0% in 2024, then soared by 2694bps to 0.04% in 2025.
  • Business Quant data shows Return on Assets for TVTX at 0.04% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.